Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

502 public trials 139 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Recruiting

A Study of ARC-02 in B-cell NHL

NCT07691606

Conditions
B-cell Non Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations
  • Start Cala Los Angeles, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • NYU Langone New York, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
View all 29 locations
View Trial Details
Recruiting

Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma

NCT06445517

Conditions
Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • Shanghai Jiao Tong University School of Medicine-Ruijin Hospital Shanghai, Shanghai Municipality, China
  • Tianjin Medical University Cancer Institute&Hospital Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06634589

Conditions
B-cell Lymphoma, B-cell Malignancy, Disease Attributes, +15 more
Locations
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • University of Southern California Norris Comprehensive Los Angeles, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 50 locations
View Trial Details
Recruiting

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

NCT06742996

Conditions
B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Ucsf Fresno Fresno, California, United States
  • Kaiser Permanente Southern California Irvine, California, United States
View all 155 locations
View Trial Details
Recruiting

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

NCT07205315

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +31 more
Locations
  • Zhengzhou Yihe Hospital Zhengzhou, Henan, China
  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT05254743

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +20 more
Locations
  • Pacific Cancer Medical Center, Inc Anaheim, California, United States
  • TOI Clinical Research Cerritos, California, United States
  • Stanford School of Medicine-Cancer Clinical Trials Office Palo Alto, California, United States
  • California Cancer Associates for Research and Excellence San Marcos, California, United States
View all 143 locations
View Trial Details
Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

NCT04792489

Conditions
Central Nervous System Lymphoma, Central Nervous System Neoplasms, Hemic and Lymphatic Diseases, +22 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • UC San Diego Health La Jolla, California, United States
View all 32 locations
View Trial Details
Recruiting

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

NCT07101328

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +23 more
Locations
  • City of Hope Duarte, California, United States
  • University of Colorado Denver - School of Medicine - Anschutz Medical Campus Aurora, Colorado, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Yale University School of Medicine - Yale Cancer Center New Haven, Connecticut, United States
View all 50 locations
View Trial Details

Related conditions